Commonwealth Equity Services’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,925
Closed -$433K 4293
2024
Q4
$433K Buy
+10,925
New +$414K ﹤0.01% 3082
2022
Q1
Sell
-8,925
Closed -$367K 3804
2021
Q4
$367K Buy
8,925
+200
+2% +$8.84K ﹤0.01% 2793
2021
Q3
$405K Buy
8,725
+835
+11% +$36.4K ﹤0.01% 2640
2021
Q2
$315K Buy
7,890
+906
+13% +$38.7K ﹤0.01% 2847
2021
Q1
$375K Buy
6,984
+2,141
+44% +$123K ﹤0.01% 2559
2020
Q4
$237K Buy
+4,843
New +$224K ﹤0.01% 2778

Other funds holding VCYT

Commonwealth Equity Services's VCYT Position: Q1 2025 in Review

Commonwealth Equity Services sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 10,925 shares — an estimated $433K sold.

Commonwealth Equity Services first reported a position in VCYT in Q4 2020 and held it in 6 quarters. The position peaked at $433K in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Commonwealth Equity Services reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 10,925 Veracyte shares in Q1 2025, an estimated $433K.
  • Commonwealth Equity Services first reported a position in Veracyte in Q4 2020 and held it in 6 quarters.
  • Commonwealth Equity Services's Veracyte position peaked at $433K in Q4 2024.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Commonwealth Equity Services's 13F filing for Q1 2025, filed 9 May 2025.